Table of Contents [26–50 of 95 articles]

• Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions, Atsushi Ogata and Toshio Tanaka
  Volume 2012 (2012), Article ID 946048, 14 pages
• Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease, Courtney L. Kraus and Susan M. Culican
  Volume 2012 (2012), Article ID 203819, 6 pages
• Table of Contents for Year 2011
• Systemic Sclerosis 2011, Lorinda Chung, Oliver Distler, Laura Hummers, Eswar Krishnan, and Virginia Steen
  Volume 2011 (2011), Article ID 308231, 2 pages
• Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges, Cristina Rigamonti, Dimitrios P. Bogdanos, Maria G. Mytilinaiou, Daniel S. Smyk, Eirini I. Rigopoulou, and Andrew K. Burroughs
  Volume 2011 (2011), Article ID 976427, 12 pages
• Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature, Maurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, Piercarlo Sarzi-Puttini, and Fabiola Atzeni
  Volume 2011 (2011), Article ID 845496, 6 pages
• A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis, T. W. van Hal, L. van Bon, and T. R. D. J. Radstake
  Volume 2011 (2011), Article ID 824972, 7 pages
• The Role of Intravenous Immunoglobulin Preparations in the Treatment of Systemic Sclerosis, Marta Baleva and Krasimir Nikolov
  Volume 2011 (2011), Article ID 829751, 4 pages
• Gastric Antral Vascular Ectasia in Systemic Sclerosis, Jill Johnson and Chris T. Derk
  Volume 2011 (2011), Article ID 305238, 3 pages
• PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers: Current Status of Clinical Trials, Ann J. Impens, Kristine Phillips, and Elena Schiopu
  Volume 2011 (2011), Article ID 392542, 5 pages
• Basal Activation of Type I Interferons (Alpha2 and Beta) and 2′5′OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis, Danilo Bretas de Oliveira, Gabriel Magno de Freitas Almeida, Antônio Carlos Martins Guedes, Flávia Patrícia Sena Teixeira Santos, Claudio Antônio Bonjardim, Paulo César Peregrino Ferreira, and Erna Geessien Kroon
  Volume 2011 (2011), Article ID 275617, 6 pages
• Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis, Kait Arefiev, David F. Fiorentino, and Lorinda Chung
  Volume 2011 (2011), Article ID 201787, 7 pages
• Radiological Classification of Glenoid Deformity in Rheumatoid Arthritis, Naoki Miyoshi, Naoki Suenaga, Kou Katayama, Naomi Oizumi, Hiroshi Yamaguchi, and Takeo Matsuno
  Volume 2011 (2011), Article ID 239894, 6 pages
• Vascular Changes in Bleomycin-Induced Scleroderma, Toshiyuki Yamamoto and Ichiro Katayama
  Volume 2011 (2011), Article ID 270938, 5 pages
• Canadian Pregnancy Outcomes in Rheumatoid Arthritis and Systemic Lupus Erythematosus, Cheryl Barnabe, Peter D. Faris, and Hude Quan
  Volume 2011 (2011), Article ID 345727, 6 pages
• Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease, Tamiko R. Katsumoto, Shelia M. Violette, and Dean Sheppard
  Volume 2011 (2011), Article ID 208219, 7 pages
• Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies, Jessica Gordon and Robert Spiera
  Volume 2011 (2011), Article ID 842181, 8 pages
• Experimental Pharmacology of Glucosamine Sulfate, Riccardo Chiusaroli, Tiziana Piepoli, Tiziano Zanelli, Paola Ballanti, Marco Lanza, Lucio C. Rovati, and Gianfranco Caselli
  Volume 2011 (2011), Article ID 939265, 8 pages
• Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights, Alessandra Pontillo, Nicola Di Toro, Paolo Edomi, A. Shadlow, A. Ammadeo, M. Gattorno, T. Not, L. Lepore, and S. Crovella
  Volume 2011 (2011), Article ID 870214, 6 pages
• Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis, M. E. Hettema, H. Bootsma, R. Graaff, R. de Vries, C. G. M. Kallenberg, and A. J. Smit
  Volume 2011 (2011), Article ID 417813, 6 pages
• The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis, Theresa C. Barnes, Marina E. Anderson, and Robert J. Moots
  Volume 2011 (2011), Article ID 721608, 6 pages
• Low-Dose Naltrexone for Pruritus in Systemic Sclerosis, Tracy Frech, Kirsten Novak, Monica P. Revelo, Maureen Murtaugh, Boaz Markewitz, Nathan Hatton, Mary Beth Scholand, Edward Frech, David Markewitz, and Allen D. Sawitzke
  Volume 2011 (2011), Article ID 804296, 5 pages
• Apoptosis Modulation as a Promising Target for Treatment of Systemic Sclerosis, Stéphane Chabaud and Véronique J. Moulin
  Volume 2011 (2011), Article ID 495792, 13 pages
• Parotid Gland Biopsy as an Additional Diagnostic Tool for Supporting the Diagnosis of Sjögren's Syndrome, Muhammad S. Soyfoo, Xavier Catteau, and Christine Delporte
  Volume 2011 (2011), Article ID 302527, 4 pages
• B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence, Dimitrios Daoussis, Stamatis-Nick C. Liossis, Georgios Yiannopoulos, and Andrew P. Andonopoulos
  Volume 2011 (2011), Article ID 214013, 7 pages
• Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids, Jörg Jerosch
  Volume 2011 (2011), Article ID 969012, 17 pages